Skip to main content
Fig. 4 | Pediatric Rheumatology

Fig. 4

From: Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis

Fig. 4

Comparison of changes in clinical indicators before and after treatment in the two groups. a-d) Levels of white blood cells, fibrinogen, ferritin and IL-2R, which are all inflammatory markers. Normal range values of WBC, fibrinogen, ferritin, and IL-2R are ≤10 × 109/L, ≤ 4 g/L, ≤ 500 μg/L and ≤ 6400 pg/mL, respectively. The numbers on the x-axis of each graph represent the number of days before and after treatment

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096